Searched for
ALEMBIC PHARMA Q2
Bonus bonanza! Last date to buy Brigade Enterprises shares for 1:3 bonus issue rewardBrigade Enterprises in May announced its first bonus issue in around seven years, along with the release of its Q4 results. It said its boa...- Zee hits 48-week TV share high on Hindi, regional gainsZee Entertainment Enterprises' television network reached an 18.6% market share in urban India. This marks a 48-week high. Gains were seen ...
- DLF sells The Dahlias apartment to Madhusudan Kela for Rs 121 croreDLF has sold a luxury apartment in The Dahlias for Rs 120.71 crore. This transaction sets a new benchmark for Gurgaon's real estate market....
- BenQ bets big on B2B segment, but its biggest opportunity may still be in home entertainmentBenQ is integrating on-device generative AI into Indian classrooms with its new RP05 interactive display, simplifying teaching tasks. Beyon...
- ETMarkets PMS Talk | The best alpha comes from spotting inflection points before the market does: Anuj JainAnuj Jain of Green Portfolio emphasizes identifying businesses at the cusp of transformation for alpha, not momentum. He highlights discipl...
- Inflation in June quarter likely to undershoot RBI forecast, rate hike probability drops ahead of monsoon risksIndia's inflation is giving the Reserve Bank of India room to hold interest rates through the first quarter of fiscal year 2027. However, r...
- Flexible office space market crosses 100 million sq ft mark, GCCs driving growthIndia's flexible workspace industry wrapped up FY26 on a high note, showcasing impressive double-digit revenue growth alongside rising prof...
- Quant Small Cap Fund raises stake in Adani Enterprises and 8 others, trims in Aurobindo Pharma and 4 moreQuant Small Cap Fund increased exposure to Adani Enterprises and eight other stocks in May while reducing holdings in Aurobindo Pharma and ...
- Market Trading Guide: Allied Blenders among 2 stock recommendations for FridayDomestic markets recovered modestly on easing oil prices and selective buying in banking and pharma stocks. Analysts have recommended Allie...
- AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...
- A home that washes, cools and thinks for you: Inside LG's 'Zero Labor Home' vision for IndiaLG Electronics is building a future home powered by artificial intelligence. Intelligent appliances, connected platforms, and robots will w...
- Zee Entertainment shares rise over 3% ahead of FIFA World Cup, Rs 2,300-crore fundraising plansZee Entertainment Enterprises' shares rose after its board approved raising at least Rs 2,300 crore to fund strategic initiatives and bolst...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Betting big on mid and smallcaps; largecaps most expensive on PEG basis, says Dinshaw IraniHelios Mutual Fund is shifting investments from large companies to mid and small companies. This move follows earnings growth trends where ...
- Rupee to average around 96/USD in FY27; risks from oil, dollar persist: Motilal OswalThe Indian rupee is projected to average around 96 against the US dollar in FY27. However, this outlook faces potential challenges includin...
- India's current account deficit to stand at 1.8% of GDP for FY27: ICICI Bank Global Market ReportIndia is expected to see a current account deficit of 1.8 per cent of GDP in FY27 as against around 2 per cent projected earlier. This adju...
- Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, VedantaIndian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...
- Flexi-staffing industry in India sees 8% YoY growth in new employment in 2025-26: ISF reportThe push for formal employment, strongly supported by the staffing industry, has been instrumental in bringing more workers into structured...
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
Load More
